(AFX UK Focus) 2007-11-19 16:06 GMT: AstraZeneca says European Patent Office rules Nexium, Losec tablet patent valid (Interactive Investor)
(AFX UK Focus) 2007-11-19 16:06 GMT: AstraZeneca says European Patent Office rules Nexium, Losec tablet patent valid (Interactive Investor)
LONDON (Thomson Financial) – AstraZeneca has announced that the European Patent Office has ruled that a patent for multiple unit pellet formulation (MUPS) used in Nexium and Losec is still valid in amended form, despite four oppositions from generic drug manufacturers.